Health Canada is reviewing a new multiple sclerosis drug that has been linked to 11 deaths.
There have been no reports of deaths in Canada of people taking the Novartis drug, which is sold under the brand name Gilenya.
Health Canada says that of the deaths outside the country, it's not clear whether the drug itself caused them, or whether other factors played a role.
Both the U.S. Food and Drug Administration and the European Medicines Agency had earlier announced that they were undertaking reviews of Gilenya.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309